Quality of Life in Younger Leukemia and Lymphoma Survivors

Pain Clinical Trial

Official title:

Quality of Life in Young Adult Survivors of Hematologic Malignancies

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00956475
• Other study ID #: CASE11Z08
• Secondary ID: P30CA043703CASE1
• Status: Completed
• Phase: Phase 1
• First received: August 8, 2009
• Last updated: August 23, 2011
• Start date: October 2008
• Est. completion date: August 2011

Study information

• Verified date: August 2011
• Source: Case Comprehensive Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

RATIONALE: Collecting information about the effect of hematologic cancer and its treatment on quality of life may help doctors learn more about the disease and plan the best treatment.

PURPOSE: This phase I trial is studying quality of life in younger leukemia and lymphoma survivors.

Description:

OBJECTIVES:

• To collect preliminary data to determine the extent to which there is impairment in quality of life of young adult survivors of hematologic malignancies.

• To identify the most common areas of concern in these survivors.

• To explore patterns of quality-of-life impairment associated with age, gender, and type of treatment (transplant vs non-transplant) in these survivors.

OUTLINE: Patients are assessed in a telephone interview using a brief demographic and clinical data form. Patients then undergo quality-of-life assessment by the Cancer Patient/Cancer Survivor Version questionnaire via telephone.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 48
• Est. completion date: August 2011
• Est. primary completion date: September 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 35 Years

Eligibility

DISEASE CHARACTERISTICS:

• Survivors of leukemia (i.e., acute myelogenous leukemia, acute lymphoblastic leukemia, chronic myelogenous leukemia, or chronic lymphocytic leukemia) or lymphoma (i.e., non-Hodgkin lymphoma or Hodgkin lymphoma) who have received any cytotoxic or radiation therapy

• Received treatment for leukemia or lymphoma 1-10 years ago

PATIENT CHARACTERISTICS:

• Not specified

PRIOR CONCURRENT THERAPY:

• See Disease Characteristics

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Anxiety Disorder
• Anxiety Disorders
• Cancer Survivor
• Disease
• Fatigue
• Leukemia
• Long-term Effects Secondary to Cancer Therapy in Adults
• Lymphoma
• Lymphoproliferative Disorder
• Lymphoproliferative Disorders
• Pain
• Psychosocial Effects of Cancer and Its Treatment
• Small Intestine Cancer

Intervention

Behavioral:
• telephone-based intervention
Patients are assessed in a telephone interview using a brief demographic and clinical data form. Patients then undergo quality-of-life assessment by the Cancer Patient/Cancer Survivor Version questionnaire via telephone.

Other:
• questionnaire administration
Patients are assessed in a telephone interview using a brief demographic and clinical data form. Patients then undergo quality-of-life assessment by the Cancer Patient/Cancer Survivor Version questionnaire via telephone.

Procedure:
• assessment of therapy complications
questionnaire via telephone
• fatigue assessment and management
questionnaire via telephone
• psychosocial assessment and care
questionnaire via telephone
• quality-of-life assessment
questionnaire via telephone

Locations

Country	Name	City	State
United States	Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center	Cleveland	Ohio

Sponsors (2)

Lead Sponsor	Collaborator
Case Comprehensive Cancer Center	National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quality of life		1-10 years after treatment	No
Primary	Most common areas of concern		1-10 years after treatment	No